stockrowHaemonetics Corporation
HAE Healthcare Medical Devices
Haemonetics Corporation’s revenue for fiscal 2026 (year ended March 2026) was $1.3 billion, down 1.97% from fiscal 2025.
- Revenue
- +9.30%
- EPS
- +25.9%
- Free cash flow
- +20.4%
- Total debt
- +21.0%
Quarter to September 2026, against a year earlier
Follow HAE
Alert me
Haemonetics Corporation (HAE) Book value per share
Haemonetics Corporation's book value per share at the end of fiscal 2026 was 16.9×, unchanged from fiscal 2025. At the end of the quarter to 30 September 2026 it was 19.7×. Over the past ten years it has ranged from 11.6× (fiscal 2020) to 18.9× (fiscal 2024); the current reading is higher than 92% of that period. Haemonetics Corporation ranks 21st of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 16.9× | 3.49% |
| FY2025 | 16.3× | (13.85%) |
| FY2024 | 18.9× | 17.53% |
| FY2023 | 16.1× | 9.72% |
| FY2022 | 14.7× | 1.71% |
| FY2021 | 14.4× | 24.63% |
| FY2020 | 11.6× | (10.63%) |
| FY2019 | 13.0× | (9.13%) |
| FY2018 | 14.3× | (0.64%) |
| FY2017 | 14.4× | 1.28% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 19.7× | 7.01% |
| Jun 2026 | 18.5× | 9.33% |
| Mar 2026 | 16.9× | (13.35%) |
| Dec 2025 | 19.5× | 9.16% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | 284× |
| BIO Bio-Rad Laboratories, Inc. compare | 284× |
| ITGR Integer Holdings Corporation compare | 50.7× |
| LIVN LivaNova PLC compare | 24.9× |
| HAE Haemonetics Corporation | 19.7× |
| BRKR Bruker Corporation compare | 15.1× |
| AXGN AxoGen, Inc. compare | 9.0× |
| TXG 10x Genomics compare | 6.4× |
| IRTC iRhythm Holdings, Inc. compare | 5.4× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on HAE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement